Genome browser tracks of the ChIP-seq data in Figure 4A show the overlap in increased DNMT3B enrichment, reduced OCT1 binding, and reduced H3K36me3 occupancy at enhancer regions of PITPNC1 and LINC00910, in MCF10CA1a cells treated with PTS (red peaks) as compared with control MCF10CA1a breast cancer cells (vehicle-treated, blue peaks). This evidence concerns the gene DNMT3B and breast cancer.